An evaluation of L-dopa in Parkinson patients.
D003679:Deglutition / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005684:Gait / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013060:Speech / Q000187:drug effects; D014831:Voice / Q000187:drug effects
D004295:Dihydroxyphenylalanine